Ontex announced its 2024 full year results.

Ontex continues its share buyback program, repurchasing 57,000 shares during the work week ending February 14, 2025. This brings its total number treasury shares to 1,712,712, representing 2.08% of all issued shares.

Ontex continues its share buyback program, repurchasing 105,668 shares during the work week ending January 31, 2025. This brings its total number treasury shares to 1,655,712, representing 2.01% of all issued shares.

Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup. The transaction includes Ontex’s business in Türkiye and related export business, as well as its plant in Istanbul. Ontex aims to complete the transaction in the course of the third quarter of 2025, subject to approval by the Turkish competition authority.

Ontex continues its share buyback program, repurchasing 11,129 shares during the work week ending January 31, 2025. This brings its total number treasury shares to 1,550,044, representing 1.88% of all issued shares.

Ontex continues its share buyback program, repurchasing 67,060 shares during the work week ending January 24, 2025. This brings its total number treasury shares to 1,538,915, representing 1.87% of all issued shares.

Ontex will share its Q4 and FY 2024 results on Wednesday, February 19, 2025 at 07:00 CET / 06:00 BT.

Ontex Academy empowers healthcare professionals in continence care through high-quality, interactive education. Over 2,000 certificates issued since 2024.

Ontex continues its share buyback program, repurchasing 83,800 shares during the work week ending January 17, 2025. This brings its total number treasury shares to 1,471,855, representing 1.79% of all issued shares.